Sylvia is Xconomy’s life sciences columnist. She has a Ph.D. in genetics from Harvard Medical School and studied journalism at the Boston University Center for Science and Medical Journalism. She has worked as a staff reporter for The Los Angeles Times, New Scientist Magazine, and The Wall Street Journal. Her work has also appeared in The Boston Globe, CNN.com, The New York Times, and Smithsonian Magazine. Sylvia was a Knight Science Journalism Fellow at MIT in 2004-2005.
Sylvia’s disclosure: I am married to a certain biotechnology entrepreneur/pharmaceutical executive/venture capitalist named Christoph Westphal, whom most folks in Boston know. That exposes me to a lot of smart people in the industry who are willing to speak candidly, but it also means I could be conflicted if writing about some biotechnology and pharma companies. My aim with The Pulse is not to report on specific companies, but to discuss trends involving all players in life sciences (academics, companies, regulators). Nonetheless, I will disclose any potential conflicts of interests to my readers when my editors and I deem appropriate.
One common complaint I hear from biotech entrepreneurs is that negotiating a license agreement with a university can be a nightmare. There are universities—some of them within the very top echelons... Read more »